Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.

Details

Language :

English

ISSN :

15455009

Volume :

52

Issue :

1

Database :

Complementary Index

Journal :

Pediatric Blood & Cancer

Publication Type :

Academic Journal

Accession number :

105587388

Full Text :

https://doi.org/10.1002/pbc.21784